PHOBRIGA (Brigatinib) 90mg*30's | Generic ALK Inhibitor Laos | GLT

REQUEST A QUOTE

Tap "Request a Quote" to open WhatsApp — the product details are already filled in. Just add your quantity and destination country.

  • We reply within 24 hours with pricing, availability & COA
  • Serves individuals and institutions worldwide

Prefer email? [email protected] · +86 15234153837

Share
Product description

Generic Information: PHOBRIGA (Laos)

PHOBRIGA is a Lao-manufactured generic of brigatinib, produced by Pharmaceutical Factory No.2, Vientiane, Laos (commonly known as the Lao "Second Factory"). It is supplied as 90 mg tablets in a 30-tablet pack, matching the lead-in and standard maintenance starting dose of the brigatinib regimen. As a second-generation ALK inhibitor generic, PHOBRIGA provides the same active ingredient as the originator at a lower cost.

What Is PHOBRIGA Used For?

PHOBRIGA is used to treat anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer, including in patients who have progressed on or cannot tolerate crizotinib. It is an oral, once-daily monotherapy that keeps treatment simple and home-based, and it is prescribed only after a genetic test confirms the ALK rearrangement.

How Does PHOBRIGA (Brigatinib) Work?

The active ingredient brigatinib is a next-generation ALK inhibitor that also targets ROS1, IGF-1R, and FLT-3. It shuts down ALK-driven growth signaling and penetrates the brain, which helps control brain metastases. The generic PHOBRIGA reproduces the same mechanism and active ingredient as the originator at a more accessible price.

Indications

PHOBRIGA is indicated for adults with ALK-positive, locally advanced or metastatic NSCLC. A confirmed ALK rearrangement is required before prescribing. The medicine is not suitable for ALK-negative tumors and is not indicated for small-cell lung cancer.

Dosage

The standard schedule is 90 mg once daily for the first 7 days, then 180 mg once daily if tolerated. The 90 mg tablets in this listing support the lead-in phase and the 90 mg maintenance dose. Take the tablet with or without food at the same time each day and swallow it whole. Do not double up on a missed or vomited dose.

Side Effects

Common side effects include diarrhea, rash, cough, high blood pressure, fatigue, nausea, muscle pain, and headache. Blood pressure should be checked regularly, and diarrhea is usually manageable with supportive care. Interstitial lung disease is rare but serious and requires permanent discontinuation if confirmed.

Storage

Store PHOBRIGA below 30°C in a dry place, inside the original packaging, and away from children. There is no cold-chain requirement.

Why Choose the GLT?

For patients who pay for treatment themselves, a Lao generic such as PHOBRIGA is a far more economical option than the originator brand, whose Western list price can be several times higher. GLT sources from established manufacturers and provides the documentation needed for international delivery, so patients can keep up affordable, uninterrupted therapy.

How to Order

To order PHOBRIGA through GLT, contact us on WhatsApp at +86 15234153837 or email [email protected]. Tell us the strength, quantity, and your country, and our team will confirm stock, sourcing origin, and delivery details. We serve hospitals, pharmacies, and individual patients alike.

FAQ

Is PHOBRIGA a generic of brigatinib? Yes. PHOBRIGA is a Lao-manufactured generic of brigatinib, produced by Pharmaceutical Factory No.2, Vientiane, Laos.

What strength does PHOBRIGA come in? This listing is the 90 mg strength in a 30-tablet box, which matches the lead-in dose and the standard 90 mg maintenance dose of the brigatinib schedule.

Where can I buy generic brigatinib? Generic brigatinib can be sourced through international suppliers such as GLT. Always verify the supplier and request proper documentation before purchasing.

Related Oncology Products

Tirzema (Tirzepatide) 2.5/5/7.5mg/0.5mL Single-Dose Pen | Incepta Bangladesh | GLT

Tirzema — Incepta Pharmaceuticals tirzepatide single-dose pen, three official strengths (2.5/5/7.5mg/0.5mL) for T2DM and weight...

Palutini (Baricitinib) 4mg | Generic JAK1/JAK2 Inhibitor | Trans Continental Life Science & Pharmaceuticals (TLPH) | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Trans Continental Life Science & Pharmaceuticals (TLPH) (Laos) — an...

LuciAvat (Avatrombopag) 20mg*28 Tablets | Lucius Pharmaceuticals Laos | GLT

LuciAvat — avatrombopag 20mg (23.6mg maleate) film-coated tablets by Lucius Pharmaceuticals (Lao) Co., Ltd., Vientiane

Olumiant (Baricitinib) 2mg/4mg Tablets | JAK1/JAK2 Inhibitor | Eli Lilly USA | GLT

Eli Lilly's selective JAK1/JAK2 inhibitor for rheumatoid arthritis, atopic dermatitis and severe alopecia areata.

Zepbound (Tirzepatide) 2.5–15mg/0.5mL Single-Dose Pen | Eli Lilly USA | GLT

Zepbound — Eli Lilly tirzepatide single-dose pen, six US strengths (2.5–15mg/0.5mL) for chronic weight management...

Eltrombopag (Promacta) 25mg/50mg Tablets | US Originator TPO-R Agonist | GLT

Novartis originator Promacta (eltrombopag) 25mg & 50mg, 30 tablets

Barinat (Baricitinib) 4mg | Generic JAK1/JAK2 Inhibitor | Natco Pharma Limited | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Natco Pharma Limited (India) — an affordable alternative to Olumiant...

KangQuXin 康曲欣 (Avatrombopag) 20mg*10 Tablets | Beijing Continent Gyre | GLT

KangQuXin — avatrombopag by Beijing Continent Pharmaceutical (Gyre Therapeutics, Nasdaq: GYRE), China Mainland